title: The impact of allograft nephrectomy on percent panel reactive antibody and clinical outcome.
authors.affiliation: Department of Surgery/Urology, London Health Sciences Centre, London, Ontario, Canada.
authors.forename: A K
authors.initials: AK
authors.lastname: Khakhar
authors.forename: V B
authors.initials: VB
authors.lastname: Shahinian
authors.forename: A A
authors.initials: AA
authors.lastname: House
authors.forename: N
authors.initials: N
authors.lastname: Muirhead
authors.forename: D J
authors.initials: DJ
authors.lastname: Hollomby
authors.forename: S H
authors.initials: SH
authors.lastname: Leckie
authors.forename: V C
authors.initials: VC
authors.lastname: McAlister
authors.forename: J L
authors.initials: JL
authors.lastname: Chin
authors.forename: A M
authors.initials: AM
authors.lastname: Jevnikar
authors.forename: P P W
authors.initials: PP
authors.lastname: Luke
mesh_terms: D000208:Acute Disease; D000328:Adult; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000601:surgery*; D006801:Humans; D007518:Isoantibodies / Q000097:blood*; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000276:immunology* / Q000473:pathology; D009392:Nephrectomy; D011183:Postoperative Complications / Q000145:classification*; D012086:Reoperation / Q000706:statistics & numerical data; D013997:Time Factors; D014184:Transplantation, Homologous / Q000276:immunology* / Q000473:pathology; D017211:Treatment Failure; D016896:Treatment Outcome
chemical_list: D007518:Isoantibodies